Royal Bank of Canada lessened its stake in shares of Molina Healthcare, Inc (NYSE:MOH - Free Report) by 23.3% in the first quarter, according to the company in its most recent filing with the SEC. The fund owned 81,044 shares of the company's stock after selling 24,675 shares during the quarter. Royal Bank of Canada owned about 0.15% of Molina Healthcare worth $26,696,000 as of its most recent SEC filing.
A number of other hedge funds also recently modified their holdings of MOH. Colonial Trust Co SC lifted its stake in shares of Molina Healthcare by 930.0% during the 4th quarter. Colonial Trust Co SC now owns 103 shares of the company's stock worth $30,000 after buying an additional 93 shares during the last quarter. Deutsche Bank AG lifted its stake in shares of Molina Healthcare by 12.6% during the 4th quarter. Deutsche Bank AG now owns 338,460 shares of the company's stock worth $98,509,000 after buying an additional 37,941 shares during the last quarter. Ethic Inc. raised its stake in Molina Healthcare by 68.2% in the 4th quarter. Ethic Inc. now owns 5,193 shares of the company's stock worth $1,511,000 after purchasing an additional 2,106 shares in the last quarter. Ensign Peak Advisors Inc raised its stake in Molina Healthcare by 100.7% in the 4th quarter. Ensign Peak Advisors Inc now owns 55,523 shares of the company's stock worth $16,160,000 after purchasing an additional 27,852 shares in the last quarter. Finally, Focus Partners Wealth raised its stake in Molina Healthcare by 224.7% in the 4th quarter. Focus Partners Wealth now owns 2,052 shares of the company's stock worth $597,000 after purchasing an additional 1,420 shares in the last quarter. Institutional investors and hedge funds own 98.50% of the company's stock.
Molina Healthcare Price Performance
Shares of Molina Healthcare stock traded up $10.31 during midday trading on Thursday, hitting $189.46. 969,922 shares of the company traded hands, compared to its average volume of 1,026,200. Molina Healthcare, Inc has a 12 month low of $151.95 and a 12 month high of $365.23. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.66 and a current ratio of 1.66. The stock has a market cap of $10.27 billion, a price-to-earnings ratio of 9.34 and a beta of 0.54. The firm's fifty day moving average price is $181.63 and its 200-day moving average price is $267.74.
Molina Healthcare (NYSE:MOH - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The company reported $5.48 earnings per share for the quarter, missing analysts' consensus estimates of $5.50 by ($0.02). Molina Healthcare had a return on equity of 27.72% and a net margin of 2.60%.The business had revenue of $11.43 billion for the quarter, compared to the consensus estimate of $10.94 billion. During the same period in the previous year, the firm earned $5.86 earnings per share. The company's revenue was up 15.7% compared to the same quarter last year. As a group, sell-side analysts forecast that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.
Insider Buying and Selling
In other Molina Healthcare news, Director Ronna Romney sold 700 shares of the business's stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total transaction of $107,618.00. Following the sale, the director directly owned 17,131 shares of the company's stock, valued at $2,633,719.94. The trade was a 3.93% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, COO James Woys bought 10,000 shares of Molina Healthcare stock in a transaction on Monday, August 4th. The shares were acquired at an average cost of $155.94 per share, for a total transaction of $1,559,400.00. Following the completion of the acquisition, the chief operating officer directly owned 74,331 shares in the company, valued at approximately $11,591,176.14. The trade was a 15.54% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 1.10% of the company's stock.
Analyst Ratings Changes
Several analysts have weighed in on MOH shares. Morgan Stanley cut shares of Molina Healthcare from an "overweight" rating to an "equal weight" rating and dropped their price objective for the stock from $364.00 to $266.00 in a research note on Thursday, July 10th. Wall Street Zen cut shares of Molina Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, June 29th. Mizuho dropped their price objective on shares of Molina Healthcare from $400.00 to $330.00 and set an "outperform" rating for the company in a research note on Friday, July 11th. Robert W. Baird dropped their price objective on shares of Molina Healthcare from $373.00 to $179.00 and set a "neutral" rating for the company in a research note on Friday, July 25th. Finally, Cantor Fitzgerald reiterated a "neutral" rating and issued a $210.00 price objective on shares of Molina Healthcare in a research note on Tuesday, August 26th. Three equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $225.18.
View Our Latest Research Report on MOH
Molina Healthcare Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Further Reading

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.